… μM, while SARS-CoV-2-HR1P exhibited no obvious fusion inhibitory activity up to 40 μM,
indicating that SARS-CoV-2-HR2P may be a promising therapeutic agent for SARS-CoV-2. …

… In this review, we summarize the most promising therapeutic … progress reports on these
promising repurposed options through the … insights against the SARS-CoV-2 infection ( Figure 1 ). …

… Hence, inhibition of these proteases could be a promising strategy for treatment against
SARSCoV-2. In this review, we discuss the current state of the art of developing inhibitors …

… To date, small molecule drug therapy by targeting SARS-CoV… G4s have been identified as
promising therapeutic targets. … G4 might be a promising therapeutic target of SARS-CoV-2. …

… SARS-Cov-2. Different preclinical in vitro and in vivo studies on other CoVs genetically very
close to SARS-Cov-2 suggested that promising … the rhesus macaque therapeutic remdesivir …

… Apitherapy is a promising source of … therapeutic effects associated with several bee
products that might be useful in the fight against the pandemic of the novel coronavirus (SARS-CoV-2…

… (SARS-CoV, MERS-CoV, and SARS-CoV-2). Mechanistic and in vitro analyses suggest
multiple promising therapeutic … that therapies with evidence for benefit in SARS-CoV and MERS-…

… effects of the other components on the course of SARS-CoV-2 infections, and, last but not …
simple combination therapy a promising and attractive therapeutic approach for SARS-CoV-2 …

… No proven effective therapies or vaccines for SARS-CoV-2 currently exist. The most promising
therapy up till now maybe Remdesivir, also we recommend Corticosteroids therapy for …

… On the other hand, the repurposing of the existing therapeutic … The initial clinical studies
revealed the promising therapeutic … Here, we summarize the ongoing therapeutic options that …